Faster antibiotic testing for ICU patients with bloodstream infections
Part of Infections clinical trials.
This trial tests whether reporting antibiotic sensitivity results in under 6 hours helps doctors choose the right β-lactam antibiotic faster for ICU patients with certain bloodstream infections. If you are in the ICU with a Gram-negative infection, your doctors will use a quick test to pick the best treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are in the intensive care unit (ICU) and expected to stay for at least the next 24 hours
- You have a bloodstream infection caused by a specific type of Gram-negative bacteria listed in the trial
- Your positive blood culture result is available on a weekday before 11 AM
- You are already receiving a β-lactam antibiotic as part of your initial treatment
- You or a family member agrees to take part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if a faster test to find the best antibiotic for a bloodstream infection can improve treatment and outcomes. If you have a confirmed bloodstream infection, you may be able to join.
This trial is testing a new, faster way to choose the right antibiotic for people with a blood infection caused by Enterobacterales bacteria. The goal is to see if this quick test helps doctors start the most effective treatment sooner.
This trial tests a rapid diagnostic method that identifies the bacteria in your blood more quickly than standard tests. If it works, doctors can pick the right antibiotic sooner.
This trial looks at whether a rapid molecular test can help doctors choose the right antibiotics faster for hospitalized patients. It aims to improve how antibiotics are used and reduce unnecessary side effects.
This trial uses a new blood test (called BV test) to help doctors decide if antibiotics should be stopped or continued for ICU patients with suspected or confirmed infections. It aims to reduce unnecessary antibiotic use while keeping patients safe.
This trial tests a personalized approach to choosing antibiotics for people with severe lung infections in the ICU. It uses rapid tests and computer models to find the best treatment faster, which may help you recover better.
Hear when a new Gram-negative Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.